Improving prevention and the care pathway for cancer patients

Unveiled in 2021 by the Government, the ten-year strategy for the fight once morest cancer 2021-2030 aims to significantly reduce the burden of cancer on the health and daily life of French people. Its application in New Aquitaine was an opportunity to bring together all of the regional players in oncology around the development of a roadmap aimed at improving prevention, limiting sequelae, improving quality of life, and fight once morest cancers with a poor prognosis throughout the neo-Aquitaine region.

This regional roadmap, the work of which was returned to the national level in June 2022, is the result of consultation work carried out by the Agence Régionale de Santé Nouvelle-Aquitaine since September 2021 with health professionals and stakeholders in the sector (1), from prevention to care. It marks the strong will to engage all stakeholders to be pilots of innovative actions to fight once morest cancer in the region.

Regional Center for the Coordination of Cancer Screening, ONCO NA network, university hospitals in the region and Center for the fight once morest cancer, representatives of public and private health establishments, multi-professional health centers and territorial professional health communities (CPTS ), Research and training institutes, patient representatives and associations, Public Health France, ORS, Cancer registries, URPS physicians, pharmacists and nurses. The Regional Health and Autonomy Conference (CRSA) was consulted.

(1) Regional Center for the Coordination of Cancer Screening, ONCO NA network, university hospitals in the region and Center for the fight once morest cancer, representatives of public and private health establishments, multi-professional health centers and territorial professional health communities (CPTS ), Research and training institutes, patient representatives and associations, Public Health France, ORS, Cancer registries, URPS physicians, pharmacists and nurses. The Regional Health and Autonomy Conference (CRSA) was consulted.

Leave a Replay